AVaTAR MedTech


Developer of a surgical method and associated single-use surgical instruments for autologous trileaflet reconstruction of aortic and pulmonary semilunar valves. The organization performs bench, animal, computational and clinical evaluations of the technique and devices, pursues manufacturing scale-up from additive prototypes to injection-molded biocompatible plastics, and works on regulatory and commercialization planning.

Industries

N/A

Nr. of Employees

small (1-50)


Products

Trileaflet semilunar valve reconstruction procedure and single-use surgical instrument set

A surgical technique to create a symmetric oversized trileaflet neo-valve from autologous tissue, supported by a set of engineered single-use instruments that standardize and speed the reconstruction and implantation workflow.


Services

In-person surgical workshops to evaluate technique and devices, solicit expert feedback, and support early clinical adoption.

Partnerships with universities and simulation providers for in vitro, in vivo and in silico validation of valve designs and device workflows.

Expertise Areas

  • Semilunar valve reconstruction surgical technique development
  • Preclinical testing: in vitro hydrodynamics and in vivo large-animal models
  • Computational biomechanics and in silico simulation
  • Medical device design, prototyping and scale-up planning
  • Show More (4)

Key Technologies

  • Additive manufacturing (3D printing) for rapid prototyping
  • Injection molding with biocompatible plastics
  • Pulsatile flow-loop hydrodynamic testing
  • Echocardiographic imaging for morphological and functional assessment
  • Show More (4)

News & Updates

Pulsatile in vitro tests demonstrated a functional neo-valve with increased coaptation and geometric features consistent with growth accommodation.

Acute porcine studies showed neo-valves without clinically significant regurgitation or stenosis and morphological features likely to support growth accommodation.

Computational simulations of oversized symmetric leaflets indicated maintained coaptation and progressive morphological adaptation as the aortic root enlarged.

Clinical application of the reconstruction method in real patients with mid-term follow-up; documented cases include 11 aortic and 6 pulmonary procedures.

Award supporting development and commercialization of autologous trileaflet valve reconstruction tools for children.

Recognized as winner in an innovation competition for growth-accommodating valve reconstruction technology.

View All News

Similar organizations

Browse all ORGANIZATIONS

JOIN OUR MAILING LIST

Stay Connected with MTEC

Keep up with active and upcoming solicitations, MTEC news and other valuable information.